73 related articles for article (PubMed ID: 8148757)
1. [The influence of n-acetylcysteine on chemiluminescence of granulocytes in peripheral blood of patients with chronic bronchitis].
Jankowska R; Passowicz-Muszyńska E; Medrala W; Banaś T; Marcinkowska A
Pneumonol Alergol Pol; 1993; 61(11-12):586-91. PubMed ID: 8148757
[TBL] [Abstract][Full Text] [Related]
2. [The influence of vitamin A on production of oxygen free radicals and activity of granulocyte catalase in patients with chronic bronchitis].
Jankowska R; Passowicz-Muszyńska E; Banaś T; Marcinkowska A; Medrala W
Pneumonol Alergol Pol; 1994; 62(11-12):628-33. PubMed ID: 7719263
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
4. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
5. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine.
Laurent T; Markert M; Feihl F; Schaller MD; Perret C
Chest; 1996 Jan; 109(1):163-6. PubMed ID: 8549180
[TBL] [Abstract][Full Text] [Related]
6. [N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD].
Jaworska M; Gillissen A; Schärling B; Wickenburg D; Schultze-Werninghaus G
Pneumologie; 1995 Oct; 49(10):539-45. PubMed ID: 8584524
[TBL] [Abstract][Full Text] [Related]
7. [Steroid response after long-term treatment with oral N-acetylcysteine in patients with chronic obstructive bronchitis].
Evald T; Hansen M; Balsløv S; Brorson-Riis L; Hansen NC; Maltbaek N; Thorshauge H
Ugeskr Laeger; 1989 Nov; 151(46):2076-8. PubMed ID: 2688231
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis.
Schermer T; Chavannes N; Dekhuijzen R; Wouters E; Muris J; Akkermans R; van Schayck O; van Weel C
Respir Med; 2009 Apr; 103(4):542-51. PubMed ID: 19138505
[TBL] [Abstract][Full Text] [Related]
9. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
Cai S; Chen P; Zhang C; Chen JB; Wu J
Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
[TBL] [Abstract][Full Text] [Related]
10. [N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators].
Chikina SIu; Iagmurov BKh; Kopylev ID; Soodaeva SK; Chuchalin AG
Ter Arkh; 2002; 74(3):62-5. PubMed ID: 11980127
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy.
Milara J; Juan G; Peiró T; Serrano A; Cortijo J
Respiration; 2012; 83(2):147-58. PubMed ID: 22094549
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled N-acetylcysteine in combination with terbutaline.
Stiksa G; Nemcek K; Melin S
Eur J Respir Dis; 1984 May; 65(4):278-82. PubMed ID: 6723838
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials.
Grandjean EM; Berthet P; Ruffmann R; Leuenberger P
Clin Ther; 2000 Feb; 22(2):209-21. PubMed ID: 10743980
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations.
Allegra L; Dal Sasso M; Bovio C; Massoni C; Fonti E; Braga PC
Arzneimittelforschung; 2002; 52(9):669-76. PubMed ID: 12404881
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of N-acetylcysteine on the peroxidative changes of rat lungs exposed to inhalation of thinners.
Dillioglugil MO; Ilgazli A; Maral H; Sengul C; Ozdemir G; Ercin C
Respirology; 2005 Nov; 10(5):615-9. PubMed ID: 16268915
[TBL] [Abstract][Full Text] [Related]
16. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of respiratory tract diseases with N-acetylcysteine. An open therapeutic observation study of 2,512 patients].
Völkl KP; Schneider B
Fortschr Med; 1992 Jun; 110(18):346-50. PubMed ID: 1644396
[TBL] [Abstract][Full Text] [Related]
18. [N-acetylcystein in the therapy of chronic bronchitis].
Reichenberger F; Tamm M
Pneumologie; 2002 Dec; 56(12):793-7. PubMed ID: 12486618
[TBL] [Abstract][Full Text] [Related]
19. Oral doxophylline in patients with chronic obstructive pulmonary disease.
Villani F; De Maria P; Ronchi E; Galimberti M
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study of N-acetylcysteine treatment in chronic hepatitis B patients].
Wang N; Shi XF; Guo SH; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):487-9. PubMed ID: 18647523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
